The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Celgene
Stock and Other Ownership Interests - Advaxis; Celgene
Travel, Accommodations, Expenses - Advaxis; Celgene
 
Honoraria - Agios; Ambit BioSciences; Ambit BioSciences; Amgen; ARIAD; Astellas Pharma; Celgene; Cellectis; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Menarini; Novartis; Pfizer; Roche/Genentech; Seagen; SERVIER; Sunesis Pharmaceuticals
Consulting or Advisory Role - Agios; Ambit BioSciences; Amgen; ARIAD; Astellas Pharma; Celgene; Cellectis; Jazz Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Menarini; Novartis; Pfizer; Roche/Genentech; Seagen; SERVIER; Sunesis Pharmaceuticals
Speakers' Bureau - Amgen; ARIAD; Celgene; Pfizer
Research Funding - Amgen; ARIAD; Jazz Pharmaceuticals; Kite, a Gilead company; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; ARIAD; Pfizer
A randomized, open-label, phase II study of azacitidine (AZA) in combination with durvalumab in patients (pts) with previously untreated higher-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) ineligible for hematopoietic stem cell transplantation (HSCT).
 
Lewis R. Silverman
Consulting or Advisory Role - Celgene
Research Funding - Celgene
 
Hartmut Dohner
Honoraria - Abbvie; Agios; Amgen; Astex Pharmaceuticals; Celator; Celgene; Novartis; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astex Pharmaceuticals; Celator; Celgene; Novartis; Seagen; Sunesis Pharmaceuticals
Research Funding - Arog; Bristol-Myers Squibb; Celgene; Novartis; Pfizer
 
Herve Dombret
No Relationships to Disclose
 
Ghulam J. Mufti
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene
Research Funding - AstraZeneca; Celgene; Novartis
Travel, Accommodations, Expenses - Celgene; Novartis
 
Richard M. Stone
Consulting or Advisory Role - Abbvie; Agios; Amgen; Bristol-Myers Squibb; Celator; Celgene; Fujifilm; Juno Therapeutics; Karyopharm Therapeutics; Merck; Novartis; Ono Pharmaceutical; Roche/Genentech; Theradex
Research Funding - Agios (Inst); Celator (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst)
 
Shelonitda Rose
No Relationships to Disclose
 
Torsten Gerike
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Frederic Camus
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Pierre Fenaux
No Relationships to Disclose